darunavir has been researched along with cardiovascular agents in 3 studies
Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
---|---|---|---|---|---|
1,148 | 224 | 780 | 17,645 | 1,480 | 6,891 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Clotet, B; Moltó, J; Valle, M | 1 |
Berginc, K; Kristl, A | 1 |
Battegay, M; Cavassini, M; Courlet, P; Decosterd, L; Marzolini, C; Saldanha, SA; Stader, F; Stoeckle, M | 1 |
1 review(s) available for darunavir and cardiovascular agents
Article | Year |
---|---|
[Pharmacological interactions with darunavir].
Topics: Anti-HIV Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cardiovascular Agents; Contraceptives, Oral, Hormonal; Cytochrome P-450 CYP3A; Darunavir; Drug Interactions; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Microsomes, Liver; Phosphodiesterase Inhibitors; Ritonavir; Selective Serotonin Reuptake Inhibitors; Sulfonamides | 2008 |
2 other study(ies) available for darunavir and cardiovascular agents
Article | Year |
---|---|
The mechanisms responsible for garlic - drug interactions and their in vivo relevance.
Topics: Animals; Antiviral Agents; Biological Transport; Caco-2 Cells; Cardiovascular Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Garlic; Hep G2 Cells; Hepatocytes; Herb-Drug Interactions; Humans; Intestine, Small; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Plant Extracts; Rats; Rats, Wistar; Reproducibility of Results; Sulfonamides | 2013 |
Aging does not impact drug--drug interaction magnitudes with antiretrovirals.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Atorvastatin; Cardiovascular Agents; Cardiovascular Diseases; Darunavir; Drug Interactions; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Rosuvastatin Calcium; Treatment Outcome | 2020 |